MedTrace Logo

Integrated Maternal Psychosocial Assessment to Care Trial (IMPACT) Full Trial

NCT01901796 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2019-11-13

No results posted yet for this study

Summary

We hypothesize that the intervention will: (1) offer a feasible approach for providing mental healthcare to pregnant women and have a high level of acceptability by pregnant women and healthcare providers; (2) reduce symptoms of depression, stress, anxiety, and parenting stress; improve parenting competence, coping, and relationship adjustment compared to usual care; and (3) reduce the risk of poor maternal-infant attachment. As such, this early intervention holds promise for reducing maternal mental health morbidity and its negative influences on infants, children, and families.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy- an effective, non-pharmacological treatment for depression and anxiety.

Sponsors & Collaborators

  • Norlien Foundation

    collaborator OTHER

  • Women and Children's Health Research Institute, Canada

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Dawn A Kingston, Ph.D · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01901796 on ClinicalTrials.gov